Inappropriate commercial presentation of selected drugs and associated overcost

Saved in:
Bibliographic Details
Published in:Farmacia hospitalaria 2006-05, Vol.30 (3), p.195-196
Main Authors: Toledano Mayoral, G, Salmerón García, A, Román Márquez, E, Cabeza Barrera, J
Format: Article
Language:Spanish
Subjects:
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - economics
Boronic Acids - administration & dosage
Boronic Acids - economics
Bortezomib
Costs and Cost Analysis
Dosage Forms - standards
Drug Industry - standards
Ergocalciferols - administration & dosage
Ergocalciferols - economics
Infliximab
Porphyrins - administration & dosage
Porphyrins - economics
Pyrazines - administration & dosage
Pyrazines - economics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 196
container_issue 3
container_start_page 195
container_title Farmacia hospitalaria
container_volume 30
creator Toledano Mayoral, G
Salmerón García, A
Román Márquez, E
Cabeza Barrera, J
description
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68893054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68893054</sourcerecordid><originalsourceid>FETCH-LOGICAL-p548-212ac32d812895c24f3605fad7ab15f5065feea43baa4046ca055da086a61f433</originalsourceid><addsrcrecordid>eNo1kMtOwzAURL0A0VL4BeQVu0h-11miikelSt10H93a1ygoiYNvgsTfE0RZzebMaGau2FpKLSqnjV6xW6IPIazaKnnDVtLVdW2dX7PjfoBxLHksLUzIQ-57LKGFjo8FCYcJpjYPPCdO2GGYMPJY5nfiMEQORDn8-iLPX4st03THrhN0hPcX3bDTy_Np91Ydjq_73dOhGq3xlZIKglbRS-VrG5RJ2gmbIG7hLG2ywtmECEafAYwwLoCwNoLwDpxMRusNe_yLXap_zkhT07cUsOtgwDxT47yvtbBmAR8u4HzuMTbLzh7Kd_P_gP4B4TRXuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68893054</pqid></control><display><type>article</type><title>Inappropriate commercial presentation of selected drugs and associated overcost</title><source>Elsevier ScienceDirect Journals</source><creator>Toledano Mayoral, G ; Salmerón García, A ; Román Márquez, E ; Cabeza Barrera, J</creator><creatorcontrib>Toledano Mayoral, G ; Salmerón García, A ; Román Márquez, E ; Cabeza Barrera, J</creatorcontrib><identifier>ISSN: 1130-6343</identifier><identifier>PMID: 16999568</identifier><language>spa</language><publisher>Spain</publisher><subject>Antibodies, Monoclonal - administration &amp; dosage ; Antibodies, Monoclonal - economics ; Boronic Acids - administration &amp; dosage ; Boronic Acids - economics ; Bortezomib ; Costs and Cost Analysis ; Dosage Forms - standards ; Drug Industry - standards ; Ergocalciferols - administration &amp; dosage ; Ergocalciferols - economics ; Infliximab ; Porphyrins - administration &amp; dosage ; Porphyrins - economics ; Pyrazines - administration &amp; dosage ; Pyrazines - economics</subject><ispartof>Farmacia hospitalaria, 2006-05, Vol.30 (3), p.195-196</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16999568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toledano Mayoral, G</creatorcontrib><creatorcontrib>Salmerón García, A</creatorcontrib><creatorcontrib>Román Márquez, E</creatorcontrib><creatorcontrib>Cabeza Barrera, J</creatorcontrib><title>Inappropriate commercial presentation of selected drugs and associated overcost</title><title>Farmacia hospitalaria</title><addtitle>Farm Hosp</addtitle><subject>Antibodies, Monoclonal - administration &amp; dosage</subject><subject>Antibodies, Monoclonal - economics</subject><subject>Boronic Acids - administration &amp; dosage</subject><subject>Boronic Acids - economics</subject><subject>Bortezomib</subject><subject>Costs and Cost Analysis</subject><subject>Dosage Forms - standards</subject><subject>Drug Industry - standards</subject><subject>Ergocalciferols - administration &amp; dosage</subject><subject>Ergocalciferols - economics</subject><subject>Infliximab</subject><subject>Porphyrins - administration &amp; dosage</subject><subject>Porphyrins - economics</subject><subject>Pyrazines - administration &amp; dosage</subject><subject>Pyrazines - economics</subject><issn>1130-6343</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNo1kMtOwzAURL0A0VL4BeQVu0h-11miikelSt10H93a1ygoiYNvgsTfE0RZzebMaGau2FpKLSqnjV6xW6IPIazaKnnDVtLVdW2dX7PjfoBxLHksLUzIQ-57LKGFjo8FCYcJpjYPPCdO2GGYMPJY5nfiMEQORDn8-iLPX4st03THrhN0hPcX3bDTy_Np91Ydjq_73dOhGq3xlZIKglbRS-VrG5RJ2gmbIG7hLG2ywtmECEafAYwwLoCwNoLwDpxMRusNe_yLXap_zkhT07cUsOtgwDxT47yvtbBmAR8u4HzuMTbLzh7Kd_P_gP4B4TRXuw</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Toledano Mayoral, G</creator><creator>Salmerón García, A</creator><creator>Román Márquez, E</creator><creator>Cabeza Barrera, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200605</creationdate><title>Inappropriate commercial presentation of selected drugs and associated overcost</title><author>Toledano Mayoral, G ; Salmerón García, A ; Román Márquez, E ; Cabeza Barrera, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p548-212ac32d812895c24f3605fad7ab15f5065feea43baa4046ca055da086a61f433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2006</creationdate><topic>Antibodies, Monoclonal - administration &amp; dosage</topic><topic>Antibodies, Monoclonal - economics</topic><topic>Boronic Acids - administration &amp; dosage</topic><topic>Boronic Acids - economics</topic><topic>Bortezomib</topic><topic>Costs and Cost Analysis</topic><topic>Dosage Forms - standards</topic><topic>Drug Industry - standards</topic><topic>Ergocalciferols - administration &amp; dosage</topic><topic>Ergocalciferols - economics</topic><topic>Infliximab</topic><topic>Porphyrins - administration &amp; dosage</topic><topic>Porphyrins - economics</topic><topic>Pyrazines - administration &amp; dosage</topic><topic>Pyrazines - economics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toledano Mayoral, G</creatorcontrib><creatorcontrib>Salmerón García, A</creatorcontrib><creatorcontrib>Román Márquez, E</creatorcontrib><creatorcontrib>Cabeza Barrera, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Farmacia hospitalaria</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toledano Mayoral, G</au><au>Salmerón García, A</au><au>Román Márquez, E</au><au>Cabeza Barrera, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inappropriate commercial presentation of selected drugs and associated overcost</atitle><jtitle>Farmacia hospitalaria</jtitle><addtitle>Farm Hosp</addtitle><date>2006-05</date><risdate>2006</risdate><volume>30</volume><issue>3</issue><spage>195</spage><epage>196</epage><pages>195-196</pages><issn>1130-6343</issn><cop>Spain</cop><pmid>16999568</pmid><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1130-6343
ispartof Farmacia hospitalaria, 2006-05, Vol.30 (3), p.195-196
issn 1130-6343
language spa
recordid cdi_proquest_miscellaneous_68893054
source Elsevier ScienceDirect Journals
subjects Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - economics
Boronic Acids - administration & dosage
Boronic Acids - economics
Bortezomib
Costs and Cost Analysis
Dosage Forms - standards
Drug Industry - standards
Ergocalciferols - administration & dosage
Ergocalciferols - economics
Infliximab
Porphyrins - administration & dosage
Porphyrins - economics
Pyrazines - administration & dosage
Pyrazines - economics
title Inappropriate commercial presentation of selected drugs and associated overcost
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A31%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inappropriate%20commercial%20presentation%20of%20selected%20drugs%20and%20associated%20overcost&rft.jtitle=Farmacia%20hospitalaria&rft.au=Toledano%20Mayoral,%20G&rft.date=2006-05&rft.volume=30&rft.issue=3&rft.spage=195&rft.epage=196&rft.pages=195-196&rft.issn=1130-6343&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68893054%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p548-212ac32d812895c24f3605fad7ab15f5065feea43baa4046ca055da086a61f433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68893054&rft_id=info:pmid/16999568&rfr_iscdi=true